WHO-GMP Certified Formulation

Ondidrop-4

Home / Products / Ondidrop-4
Ondidrop-4
Tablet

Ondidrop-4

Composition: Ondansetron IP 4 mg

Pack 20 x 10 Tablets
Type Tablet
Status Active

Product Description

Ondidrop-4 Ondidrop-4 contains Ondansetron, a potent and selective 5-HT3 receptor antagonist widely prescribed to prevent and treat nausea and vomiting caused by cancer chemotherapy, radiation therapy, and post-operative surgical recovery. Formulated as an orally disintegrating tablet, it dissolves rapidly in the mouth without requiring water, offering fast-acting relief and convenience for patients experiencing acute gastric distress or difficulty swallowing traditional pills.

Got Questions?

Frequently Asked Questions

Find answers regarding product efficacy, clinical specifications, and distribution rights.

Explore Portfolio

Related Tablets

Chat on WhatsApp